Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$0.87 - $3.13 $262,740 - $945,260
-302,000 Closed
0 $0
Q1 2020

May 07, 2020

SELL
$0.73 - $1.91 $29,200 - $76,400
-40,000 Reduced 11.7%
302,000 $287,000
Q4 2019

Feb 14, 2020

BUY
$0.48 - $1.38 $116,160 - $333,960
242,000 Added 242.0%
342,000 $472,000
Q3 2019

Nov 13, 2019

BUY
$0.47 - $1.05 $47,000 - $105,000
100,000 New
100,000 $47,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $194M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Plante Moran Financial Advisors, LLC Portfolio

Follow Plante Moran Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plante Moran Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plante Moran Financial Advisors, LLC with notifications on news.